"The innovation of our project is a refined method in which we use mass spectrometry – a method for measuring the mass of molecules – to better investigate the abundance of lysosomal proteins in patient samples. This will ultimately enable us to identify diseases more precisely," says Dr. Dominic Winter, explaining his product idea for the biopharmaceutical market. Lysosomal proteins could serve as potential biomarkers for over 200 different possible diseases. Dr. Winter is working on the project "LysoQuant - Identification of Lysosome-related Biomarkers by Targeted Mass Spectrometry" together with his doctoral students Dhriti Arora and Anne Sanner.
Ongoing funding by the Transfer Center
"The prototyping grants are aimed to promote innovative ideas and their development for the market. Over the past two years, we have supported teams from a range of disciplines - from agricultural or social sciences to medicine," says Sandra Speer, Head of the Transfer Center enaCom.
The projects are closely supported by the Transfer Center's start-up consulting team. The funding is offered by enaCom and financed by the ESC (Excellence Startup Center) individual project "U-Bo-Grow" at the University of Bonn. It is funded by the Ministry of Economic Affairs, Industry, Climate Protection and Energy (MWIKE) of the state of North Rhine-Westphalia.
Applications for funding for prototype development in 2024 can be submitted by May 31st 2024. Find all information here.
